Assignee: Nycomed GmbH

Location: Constance, DE
No. of patents: 39

Browse patents
Browse applications

Number	Title	Issue Date
8182824	Ciclesonide-containing sterile aqueous suspension The present invention provides a ciclesonide-containing sterile aqueous suspension sterilized by autoclaving, wherein the concentration of ciclesonide after autoclaving is 95% or more compared to that before autoclaving. ...	05/22/2012
8163299	Stabilized pharmaceutical product Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar. ...	04/24/2012
8106047	Triazolophthalazines The compounds of formula (I) in which R1, R2 and R3 have the meanings as given in the description are novel effective PDE2 inhibitors. ...	01/31/2012
8029811	Stabilized pharmaceutical product Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar. ...	10/04/2011
8017633	Roflumilast for the treatment of diabetes mellitus The invention relates to the use of Roflumilast and/or Roflumilast N-Oxide for the treatment of diabetes mellitus and accompanying disorders thereof. The invention additionally relates to combinations of Roflumilast and/or Roflumilast N-Oxide with other active agent...	09/13/2011
8003798	Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors Compounds of the formula I in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors. ...	08/23/2011
7988999	Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient The present invention relates to the field of pharmaceutical technology and describes a pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient, in particular an acid-labile proton pump inhibitor. The invention also relates to p...	08/02/2011
7951398	Pharmaceutical preparation comprising an active dispersed on a matrix The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation, an...	05/31/2011
7951397	Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder. ...	05/31/2011
7947744	Stable pharmaceutical products Provided herein is a stable pharmaceutical product comprising a dry powder inhalation device, and a pharmaceutical composition that comprises R,R-Formoterol L-tartrate salt, in particular crystalline R,R-formoterol L-tartrate; and ciclesonide. ...	05/24/2011
7879833	Combination medicament The invention relates to the combination of ciclesonide with formoterol. ...	02/01/2011
7851472	Triazolophthalazines The compounds of formula I in which R1 and R2 have the meanings as given in the description are novel effective PDE2 inhibitors. ...	12/14/2010
7838521	3-oxa-10-aza-phenanthrenes The compounds of formula I in which R1, R2 and R3 have the meanings as given in the description, are novel effective PDE4 inhibitors. ...	11/23/2010
7820669	2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors The compounds of a certain formula (1), in which R1, R2, R3 and R9 have the meanings as given in the description, are novel effective PDE4 inhibitors. ...	10/26/2010
7794752	Preparation and administration form comprising an acid-labile active compound Novel administration forms and preparations for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being present in the active compound units in a matrix made of a mixture comprisi...	09/14/2010
7790710	Imidazopyridine derivatives useful as iNOS inhibitors The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors. ...	09/07/2010
7790198	Preparation and administration form comprising an acid-labile active compound Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being present in the active compound units in a matrix made of a mixture comprisin...	09/07/2010
7785630	Preparation and administration form comprising an acid-labile active compound Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being present in the active compound units in a matrix made of a mixture comprisin...	08/31/2010
7776893	Use of PDE4 inhibitors for the treatment of diabetes mellitus The invention relates to the use of certain known PIDE4 inhibitors for the treatment of diabetes mellitus and accompanying disorders thereof. ...	08/17/2010
7736673	Stabilized pharmaceutical product The invention relates to the use of an adsorbent and a sealed package, for example an overwrap, to protect a pharmaceutical product in a solid state in the presence of a reducing sugar. ...	06/15/2010
7718668	Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4-inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions for use, e.g., in treatment of airway disorders. ...	05/18/2010
7671050	Triazolophthalazines The compounds of formula (I) in which R1, R2 and R3 have the meanings as given in the description are novel effective PDE2 inhibitors. ...	03/02/2010
7666872	Use for PDE5 inhibitors The present invention is concerned with the use of PDE5 inhibitors in medicine. ...	02/23/2010
7641050	Medicine pack The present invention relates to a novel type of medicine pack comprising a plurality of blister units (1), said blister units (1) each having a protective case (6), with a blister strip (4) located therein, the blister strip (4) b...	01/05/2010
7632844	2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors The compounds of formula I in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings as indicated in the description, are novel effective PDE4 inhibitors. ...	12/15/2009
7629361	Salt of (S)-pantoprazole and its hydrates The invention relates to (−)-pantoprazole magnesium and its hydrates and to medicaments comprising these compounds. ...	12/08/2009
7601737	Isotopically substituted proton pump inhibitors The invention relates to compounds of formula 1 and formula 10 and to compositions comprising these compounds and methods of treating gastrointestinal disorders by administering t...	10/13/2009
7585872	Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors The compounds of a certain formula (1), in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings as given in the description, are novel effective PDE4 inhibitors. ...	09/08/2009
7494990	2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors The compounds of a certain formula (1), in which R1, R2, R3 and R9 have the meanings as given in the description, are novel effective PDE4 inhibitors. ...	02/24/2009
7470704	Benzonaphthyridines The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors. ...	12/30/2008
7468433	Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation The invention relates to a process for the preparation of 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione[11β,16α(R)] and similar compounds, by reaction of an appropriate 16,17-ketal with cyclohexanealdehyde. ...	12/23/2008
7452998	Process for preparing optically pure active compounds The invention relates to a novel process for preparing an optically pure PPI having a sulfinyl structure using a chiral zirconium complex or a chiral hafnium complex. ...	11/18/2008
D580547	Tablet	11/11/2008
7423046	3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors Compounds of formula (I), in which R1, R2, R3, R4, R5, R6 and R7 have the meaning indicated in the description, are novel effective PDE4 inhibitors. ...	09/09/2008
7402321	Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release c...	07/22/2008
7357943	Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient The present invention relates to the field of pharmaceutical technology and describes a novel pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient, in particular an acid-labile proton pump inhibitor. The invention also r...	04/15/2008
7351723	Freeze-dried pantoprazole preparation and pantoprazole injection Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have adv...	04/01/2008
7329676	2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors The compounds of formula I in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings as indicated in the description, are novel effective PDE4 inhibitors. ...	02/12/2008
7279488	Imidazopyridine-derivatives as inducible no-synthase inhibitors The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors. ...	10/09/2007

PatentStorm

Celebrity Inventors

PatentStorm News

Assignee: Nycomed GmbH